Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
  • Carrageenan
  • Mixture Of Sulphated Polysaccharides Extracted From Red Seaweed (rhodophyceae)
  • Carrageenin
  • Mixture Of Sulfated Polysaccharides Extracted From Red Seaweed (rhodophyceae)
  • Plant Material Obtained From Various Members Of The Gigartinaceae Or Solieriaceae Families Of Red Seaweed
  • Carrageenan [ep]
  • Carrageenan [mart.]
  • Carrageenan [mi]
  • Carrageenan [fcc]
  • Carrageenan [inci]
  • Carrageenan [ii]
  • Carrageenan [hsdb]
  • Carrageenan [vandf]
  • Aec Carrageenan Gel
  • Aec Carrageenan Powder
  • Genugel Carrageenan
  • Genuvisco Carrageenan
  • Seaspen Pf
  • Calcium Carrageenan [inci]
  • Potassium Carrageenan [inci]
  • Sodium Carrageenan [inci]
  • Sea Spen [ii]
  • E-407
  • Ins-407
  • Ins No.407
  • Danish Agar (from Furcellaria Fastigiata)
  • Eucheuman (from Eucheuma Spp.)
  • Irish Moss Gelose (from Chondrus Spp.)
  • Iridophycan (from Iridaea Spp.)
  • Hypnean (from Hypnea Spp.)
  • Furcellaran Agar (from Furcellaria Fastigiata)
  • Sea Spen
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.


Route Formulation Per Unit Dose
Dental Paste
Topical Lotion 0.5%
Transdermal Film, Controlled Release 33MG
Oral Capsule 0.15MG
Oral Capsule, Extended Release 0.3MG
Oral Granule, For Reconstitution 6MG
Oral Granule, For Suspension 20.15MG
Oral Powder, For Suspension 0.3%
Oral Powder, For Suspension 1.5%
Oral Syrup
Oral Tablet 15MG

More Information

Usage Over Time